This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
National Comprehensive Cancer Network.NCCN Guidelines for Kidney Cancer Updated to Include Pazopanib for Advanced Disease; Free Webinar Discusses Updates. Media Release: 3 Nov 2009. Available from: URL: http://www.nccn.org
About this article
Cite this article
Pazopanib has been added to the Clinical Practice Guidelines in Oncology for Kidney Cancer, following its US FDA approval last month. Pharmacoecon. Outcomes News 591, 9 (2009). https://doi.org/10.2165/00151234-200905910-00020
- Tyrosine Kinase
- Renal Cell Carcinoma
- Renal Cell
- Kinase Inhibitor